News Focus
News Focus
icon url

Easka

04/17/20 6:30 PM

#10876 RE: Brusselsspirit #10875

Brusselsspirit Thanks for the link. More of a market than I thought for IS,
139M in 2019. It also says in the article that the main 2 competitors Acthar Gel and Sabril both have Orphan Drug Exclusivity in the US.